Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
It was the latest setback for the Cambridge biotech, which in August announced it would lay off 40 percent of its workforce.
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of ...
Not only did it help patients lose weight, but they were also able to keep the weight off for up to 150 days following the last dose of the medicine. Amgen plans on releasing results from phase 2 ...
Pfizer announced Tuesday it would lay off up to 800 researchers, according to a report from 'The Wall Street Journal.' Pfizer expects to have laid off 5% to 8% of its 10,000-person research staff ...
Amgen, with its obesity candidate MariTide and other promising treatments in its pipeline, could potentially surpass Eli Lilly in the obesity market. Amgen's stock is undervalued compared to Eli ...
🍬 Wana Brands co-founder Nancy Whiteman, whom Axios Denver named as a 2023 Power Player, announced yesterday she would step ...